0001104659-22-125503.txt : 20221208
0001104659-22-125503.hdr.sgml : 20221208
20221208163031
ACCESSION NUMBER: 0001104659-22-125503
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221206
FILED AS OF DATE: 20221208
DATE AS OF CHANGE: 20221208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chan Phillip P.
CENTRAL INDEX KEY: 0001442786
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36792
FILM NUMBER: 221452890
MAIL ADDRESS:
STREET 1: 1001 BRIGGS ROAD
STREET 2: SUITE 280
CITY: MOUNT LAUREL
STATE: NJ
ZIP: 08054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytosorbents Corp
CENTRAL INDEX KEY: 0001175151
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980373793
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 305 COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 973-329-8885
MAIL ADDRESS:
STREET 1: 305 COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: MedaSorb Technologies CORP
DATE OF NAME CHANGE: 20060807
FORMER COMPANY:
FORMER CONFORMED NAME: GILDER ENTERPRISES INC
DATE OF NAME CHANGE: 20020611
4
1
tm2232267-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-12-06
0
0001175151
Cytosorbents Corp
CTSO
0001442786
Chan Phillip P.
C/O CYTOSORBENTS CORPORATION
305 COLLEGE ROAD EAST
PRINCETON
NJ
08540
1
1
0
0
Chief Executive Officer
Common Stock
2022-12-06
4
P
0
14291
1.264
A
881570
D
Common Stock
2022-12-07
4
P
0
9850
1.26
A
891420
D
The transactions reported on this Form 4 reflect open market purchases made by the reporting person.
Includes (a) the following restricted stock units ("RSUs") that will be settled into shares of the Issuer's common stock upon vesting upon a "Change In Control" of the Issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 10,300 RSUs granted on March 15, 2018, (b) 18,700 RSUs granted on February 24, 2017, (c) 57,000 RSUs granted on June 7, 2016 and (d) 130,000 RSUs granted on April 8, 2015;
(continued from footnote 2) (b) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date) and will settle into shares of Common Stock upon vesting: (a) 24,000 RSUs granted on April 12, 2021 and unvested on the date hereof and (b) 52,667 RSUs granted on August 10, 2022 and unvested as of the date hereof; and
(continued from footnote 3) (c) 598,753 shares of the Issuer's common stock owned by the reporting person, inclusive of the total of 24,141 shares of the Issuer's common stock reported on this Form 4.
/s/ Kathleen P. Bloch attorney-in-fact for Phillip P. Chan
2022-12-08